Answers are grounded in this paper and cite their sources.
This work proposes the BioSync Architecture to improve communication efficiency in neural interfaces, suggesting a new direction for scalable systems.
This work establishes the formal transition from carrier-based (Class I) to interface-localized (Class III) communication architectures. Grounded in the principles of the Architectural Limit Theorem (Goncharenko, 2026), the paper identifies why modern mobile devices and invasive neural interfaces (BCI) are fundamentally non-scalable due to their persistent internal operational complexity — the requirement to maintain energy and cooling within the carrier itself. The author proposes the BioSync Architecture, a structural inversion that externalizes all active processes, leaving only a passive interaction node within the biological host. Key highlights of the work: Architectural Purity: The system requires no internal batteries or processors, reducing the background infrastructure overhead on the organism to zero. Throughput Potential: Direct coupling with biological receptors (specifically the vestibular sacculus) enables information transfer that bypasses traditional output channels (screens and speakers), significantly exceeding current efficiency benchmarks. Structural Safety: Safety is presented as a physical property of the architecture rather than a software-controlled variable. The use of low-temperature optical fuses ensures immediate physical decoupling in the event of an energy surge, eliminating the risk of thermal tissue damage. Unbounded Scalability: The work demonstrates how communication efficiency can scale indefinitely by ensuring that operational conditions are localized strictly at the point and moment of contact, satisfying the criterion for Class III systems. This paper defines the terminal stage of communication infrastructure development — a transition toward systems where functionality is fully decoupled from physical carriers and iterative device replacement cycles.
No takes yet. Share an insight, caveat, or question.
Roman Goncharenko (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: